Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism AMPK agonists(AMP activated protein kinase agonists), STK4 inhibitors(serine/threonine kinase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H18F2N6O3S |
InChIKeyOOEJZUUVEWCSEG-UHFFFAOYSA-N |
CAS Registry2414484-01-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | CN | 05 Apr 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | CN | 05 Apr 2023 |